Andy Goren to Male
This is a "connection" page, showing publications Andy Goren has written about Male.
Connection Strength
0.168
-
5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia. J Eur Acad Dermatol Venereol. 2021 Apr; 35(4):e243-e246.
Score: 0.012
-
Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients. J Eur Acad Dermatol Venereol. 2021 Jan; 35(1):e15-e17.
Score: 0.012
-
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men. J Eur Acad Dermatol Venereol. 2021 Jan; 35(1):e13-e15.
Score: 0.012
-
Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals. J Am Acad Dermatol. 2020 12; 83(6):e401-e402.
Score: 0.012
-
Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19? J Cosmet Dermatol. 2020 Jul; 19(7):1542-1543.
Score: 0.012
-
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign". J Am Acad Dermatol. 2020 Aug; 83(2):680-682.
Score: 0.012
-
A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity. J Cosmet Dermatol. 2020 Jul; 19(7):1545-1547.
Score: 0.012
-
What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy. Dermatol Ther. 2020 Jul; 33(4):e13365.
Score: 0.012
-
Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients. Dermatol Ther. 2018 11; 31(6):e12741.
Score: 0.011
-
The effect of topical minoxidil treatment on follicular sulfotransferase enzymatic activity. J Biol Regul Homeost Agents. 2018 Jul-Aug; 32(4):937-940.
Score: 0.010
-
Social selection favours offspring prone to the development of androgenetic alopecia. J Biol Regul Homeost Agents. 2017 Oct-Dec; 31(4):1013-1016.
Score: 0.010
-
Mechanism of action of minoxidil in the treatment of androgenetic alopecia is likely mediated by mitochondrial adenosine triphosphate synthase-induced stem cell differentiation. J Biol Regul Homeost Agents. 2017 Oct-Dec; 31(4):1049-1053.
Score: 0.010
-
Potential risk of developing herpes simplex encephalitis in patients treated with sildenafil following primary exposure to genital herpes. J Biol Regul Homeost Agents. 2017 Jul-Sep; 31(3):679-682.
Score: 0.010
-
Time of onset and duration of post-COVID-19 acute telogen effluvium. J Am Acad Dermatol. 2021 10; 85(4):975-976.
Score: 0.003
-
Potential risk for developing severe COVID-19 disease among anabolic steroid users. BMJ Case Rep. 2021 Feb 26; 14(2).
Score: 0.003
-
Androgen sensitivity in COVID-19 and antiandrogens: Prospective data are still needed. Dermatol Ther. 2020 11; 33(6):e14166.
Score: 0.003
-
Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS). Med Hypotheses. 2020 Oct; 143:110112.
Score: 0.003
-
Androgen sensitivity gateway to COVID-19 disease severity. Drug Dev Res. 2020 11; 81(7):771-776.
Score: 0.003
-
Identification of the sulfotransferase iso-enzyme primarily responsible for the bio-activation of topical minoxidil. J Biol Regul Homeost Agents. 2019 May-Jun,; 33(3):817-819.
Score: 0.003
-
Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients from the Indian Subcontinent. Dermatol Ther. 2018 11; 31(6):e12688.
Score: 0.003